Back to Authors

Boruta, Gina

A5117126994 | I4394709241

Mayo Clinic

Sermonix Pharmaceuticals

Citations 1

ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1 -mutated, metastatic breast cancer

Future Oncology | April 13, 2025 | Volume: 21 | Issue: 11 | Pages: 1317-1324

10.1080/14796694.2025.2481825 | PMID 40222048